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Abstract: 
Objective: To develop and validate a chromatographic method to determine the amount of drug (assay) in the 
tablets of memantine hydrochloride (MEM) using high performance liquid chromatography with refractive index 
(RI) detector.  
Methods: The chromatographic separation was achieved on C18 (250 × 4.5 mm, 5μ) column using isocratic mobile 
phase comprises of buffer (pH-6.0): Methanol (45:55 v/v) pumped at a flow rate of 1.0 ml/min. The detection of 
effluent was monitored using RI detector.  
Conclusion: The method was found to be simple, commercial, precise, accurate and robust which can be utilized for 
the determination of assay of MEM in tablets and capsules. 
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INTRODUCTION: 
Memantine Hydrochloride is often used in the 
treatment of Alzheimer’s disease (AD). 
AD can be caused due to depression, delirium, drug 
interaction, thyroid problems, excess use of alcohol, 
or certain vitamin deficiencies [1, 2]. 
Memantine HCl chemically is 1-amino-3,5-
dimethyladamantane hydrochloride (Fig. 1).  
Memantine hydrochloride occurs as a fine white to 
off-white powder and is soluble in water. Its 
molecular weight is 215.76 and molecular formula is 
C12H21N.HCL.  
It's highly basic (pKa 10.42) and lipophilic (log P 
3.28) nature suggests that it may show binding with 
(2-Napthoxy) Acetyl chloride, 9-fluorenylmethyl 
chloroformate, dansyl chloride etc due to interaction 
of its primary amine group. 
 
Fig. 1: Structure of Memantine Hydrochloride. 
MEM is used as option in a new class of AD 
treatment and showed very good results in terms of 
efficacy and safety for patients with moderate to 
severe symptoms. It has been recently approved by 
European Union and Australia for the treatment of 
moderately severe to severe AD [5]. 
The drugs which are used in treatment of AD need to 
be given in appropriate dosage regimen. Hence it is 
very important to estimate the amount of drug present 
in the dosage forms. For determination of amount of 
drug (assay) in different formulations like tablets, 
capsules etc. a simple, rapid and economical 
analytical method is required.  
 
MEM doesn’t have chromophore. This limitation of 
the MEM necessitates, selecting specialized 
analytical techniques for its quantification. Numbers 
of HPLC methods were reported for quantification of 
MEM in pharmaceutical dosage forms with specific 
techniques such as pre-column derivatization with 
UV detector [6-8], with charged aerosol detector [9]. 
The MEM quantification in biological fluids such as 
plasma and vitreous humour were also performed 
using pre-column derivatization and fluorescence 
detection [10-14]. The reported methods are 
cumbersome and time consuming with tedious 
sample preparation process.  
 
This research was focused on development of a 
simple, precise, accurate, specific and robust reverse 
phase chromatographic method using refractive index 
detector for quantification of MEM in its different 
pharmaceutical dosage forms. The developed method 
is having advantage of short run time, no 
derivatization required; hence more number of 
samples can be tested in short span of time. This 
method can be used in quality control and R&D. The 
simplicity of proposed method is economical and can 
be utilized by common laboratories. The developed 
method was validated as per International Conference 
on Harmonization (ICH) Q2(R1) guideline and 
United State of Pharmacopoeia (USP) 38 chapter 
<1225> and chapter <1092> [15-17]. The method 
found to be specific, precise, accurate and robust with 
compliance to acceptance criteria of ICH and USP 
38.  
 
EXPERIMENTAL: 
Materials and reagents: 
Memantine hydrochloride pure drug (100.0% w/w), 
tablets with label claim 30 mg of Memantine 
hydrochloride per tablet were provided by Wockhardt 
Ltd Aurangabad, Maharashtra India.  
 
HPLC grade methanol was purchased from Merck 
Chemicals, Mumbai, India. Ultrapure water was 
generated from Milli-Q water purifier. Diethylamine 
was purchased from Spectrochem, Mumbai, India. 
Orthophosphoric acid and hydrochloric acid were 
purchased from Merck Ltd, Mumbai, India. Sodium 
chloride was purchased from Merck Chemicals, 
Mumbai, India. 
 
Instruments and Methods: 
Instrumentation:  
Waters High performance liquid chromatography 
(HPLC) system with Refractive Index Detector. 
 
Chromatographic parameters: 
The chromatographic column used was a Hypersil-
BDS, C18 (250.0 × 4.6mm; 5 μm) which was 
maintained at 40º C. The mobile phase was prepared 
by mixture of ultrapure water containing 0.2% 
diethylamine (pH 6.0 adjusted with dilute 
Orthophosphoric acid) – methanol in the ratio of 
45:55 v/v. The flow rate of the mobile phase was 1.0 
ml/min. The injection volume was 50.0 µL. The 
column effluents were monitored by refractive index 
detector. The detector and column oven temperature 
was set at 40.0º C with sensitivity of 512. The sample 
and reference cell were purged with mobile phase for 
30min each with flow rate 1.0 ml/min.  
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Preparation Standard solutions: 
Weighed accurately about 50 mg of MEM working 
standard and transferred to 50 ml volumetric flask. 
The content of the flask was dissolved with mobile 
phase with sonication and volume was made up to 
mark with mobile phase as primary stock solution. 
Further 5.0 ml of prepared standard primary stock 
solution was pipetted and transferred to 50 ml 
volumetric flask and made up to the mark with 
mobile phase to get nominal concentration about100 
µg/ml.  
 
Method Validation 
Specificity 
Specificity is the ability of the method to measure the 
analyte response in the presence of its potential 
impurities or expected to present. The specificity of 
the developed LC method for MEM was carried out 
by injecting placebo, known impurities of MEM 
(Admantamine) The placebo was prepared by 
dissolving 10mg placebo in 10 ml of volumetric flask 
in mobile phase and sonicated. The volume was made 
up to the mark with mobile phase. The resulting 
solution was filtered through 0.45µ syringe filter.  
Each impurity was prepared by weighing 1mg of 
individual impurity in 10 ml volumetric flask and 
dissolved in mobile phase by sonication. The volume 
was made up to the mark with mobile phase. Further 
diluted 1ml of this solution to 10 ml with mobile 
phase. 
 
The mobile phase (blank), placebo solution, 
individual impurities (10µg/ml) and standard drug 
solution (100µg/ml) were injected in sequence for 
evaluation of specificity of proposed method. The 
chromatograms were monitored for any peak eluted 
at the retention time of drug.   
 
Precision 
Precision express the measure of how close the 
analytical results are to each other from a set of 
measurements under controlled analytical conditions. 
Precision proves random errors of the measurement.  
Precision is a measure of the degree of repeatability 
(Intra-day), intermediate precision and 
reproducibility (inter-day) of the analytical method 
under normal operating circumstances. 
Precision is usually measured as the relative standard 
deviation (RSD) of analytical results acquired from 
independently prepared quality control standards.  
Method precision was evaluated by six sample 
preparations of same homogeneous test sample of 
MEM (30mg/tablet) and calculated % assay for each 
sample preparation. The % RSD for set of six 
preparations was calculated.  
The intra-day precision was evaluated by analyzing 
six preparations of MEM (n = 6) in two different set 
in a day. The acceptance criteria for % RSD is not 
more than 2%. 
 
The intermediate precision of the method was also 
evaluated using different analyst and a different 
instrument in the same laboratory by carrying out six 
sample preparation of same test sample of MEM 
tablets and calculated % assay for all preparations. 
Calculated the %RSD for 12 results. The acceptance 
criteria for % RSD is not more than 2%. 
 
Recovery (Accuracy) 
Accuracy is extremely important in analytical method 
validation as it assures the closeness of agreement 
between a test result and the accepted reference 
value. Accuracy is expressed as trueness and involves 
a combination of random components and a common 
systematic error or bias component. The accuracy of 
the method was performed by recovery studies. 
In order to evaluate the accuracy of the proposed 
methods, a recovery test was performed by adding 
known amounts of standard solutions to the placebo 
formulation sample, followed by analysis using the 
proposed chromatographic method. 
The recovery studies were done for three different 
levels at 80%, 100% and 120% with three 
determinations of working level concentration using 
standard spiking method. 
 
The placebo was accurately weighed about 120mg 
for all level. For 80% (80µg/ml) level of recovery 
studies, 40.0 mg of MEM standard was spiked along 
with 120mg placebo and dissolved in 50ml of mobile 
phase. Further diluted 5.0 ml of this solution to 50 ml 
with mobile phase. The resulting solution was filtered 
through 0.45µ syringe filter. In same manner for 
100% and 120% recovery studies 50mg (100µg/ml) 
and 60mg (120.0µg/ml) of MEM was spiked with 
120mg of placebo respectively and prepared the 
solutions. All the above solutions were prepared in 
triplicate and were analyzed using proposed 
chromatographic condition. The recovery at each 
level was calculated by using the theoretical value 
from exact weight taken for spiking. The % recovery 
was calculated with respect to amount added. The 
acceptance criteria for % recovery are in the range of 
98 - 102%. 
 
Linearity 
The linearity of an analytical method is its ability to 
elicit test results that are directly, or by means of 
well-defined mathematical transformations, 
proportional to the concentration of analytes in the 
samples within a given range. 
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The linearity plot was constructed for MEM in the 
range of 50 to 150µg/ml. The primary stock solution 
of 1000µg/ml of MEM was prepared in mobile phase. 
From the primary stock solution, appropriate 
dilutions were made to get concentration of 50.0, 
70.0, 100.0, 120.0 and 150.0. The calibration curve 
was plotted as concentration of the respective drug 
solutions versus the peak area at each level. The 
results were statistically evaluated and correlation 
coefficient determination (r2), slope and y-intercept 
values were calculated. 
 
Robustness 
Robustness is the capacity of a method to remain 
unaffected by small deliberate variations in method 
parameters. One consequence of evaluation of 
robustness is that a series of system suitability 
parameters is established to ensure that the analytical 
procedure is maintained whenever used. In the 
present study the working concentration 100.0µg/ml 
of MEM was used for the determination of the 
robustness of the method. The following parameters 
were considered for the robustness of the proposed 
chromatographic method. 
 Effect of pH in the mobile phase (0.2) 
 Effect of organic modifier in mobile phase 
composition ( 2%) 
 Effect of flow rate (0.1) 
 Column oven and detector temperature (±2°C) 
 
Solution stability of sample and standard in 
mobile phase 
The solution stability of MEM sample was performed 
to understand stability which will be helpful to 
understand sample handling in proposed 
chromatographic method.  The sample and standard 
solution after preparation were injected immediately 
to the system considering as an initial at 0 hr as 
baseline. A solution stability of MEM was carried out 
for sample solution (100.0µg/ml) in a tightly capped 
volumetric flask at ambient temperature for 72 hr. 
The results were calculated against freshly injected 
standard. 
 
System Suitability 
The rationale of the system suitability assessment is 
to make sure that the complete testing system 
(including instrument, reagents, columns, analysts) is 
appropriate for the intended application. 
System suitability tests (SST) are vital part of liquid 
chromatographic methods. They are used to verify 
the reproducibility of the chromatographic 
parameters and system is satisfactory for the analysis 
to be done. SST is support on the concept that the 
equipment, electronics, analytical operations and 
samples to be analyzed comprise an integral system 
that can be evaluated as such. 
The system suitability test was performed in 
accordance with USP [18].  
 
Application of chromatographic method for 
determination of assay of MEM tablets: 
Assay test of MEM tablets was performed using 
developed method.  
 
RESULTS: 
Validation of chromatographic method  
Specificity: 
The overlay chromatogram (Fig. 2) of diluent, 
placebo, known impurities and standard solution 
were revealed that there is no interference at the 
retention of MEM. The developed chromatographic 
method was found to be highly specific for 
determination of assay for MEM tablets and capsules.   
 
Fig. 2: Chromatogram of Memantine HCl along with diluents, placebo and known impurities. 
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Table 2: The precision results 
Concentration 
(µg/mL) 
% RSD Absolute % difference in mean 
assay value Intra-day(n=6) Inter-day (n=12) 
100 0.47% 0.53% 0.4% 
Precision: 
The intra-day precision was evaluated by performing 
six (n = 6) assay determinations on same 
homogeneous sample of MEM tablets and the % 
RSD was found to be 0.47%.  
The % RSD for inter day precision of assay test for 
two sets (n=12) for their % assay was found to be 
0.53%.  
The absolute difference between results for 
intermediate precision found 0.4% (Table no. 2). 
 
Accuracy (Recovery) 
The % recovery at 80, 100 and 120% was found to be 
99.8±0.5, 100.1±0.5, and 100.1±0.1% respectively 
(Table no. 3). The overall mean recovery was found 
to be 100.0±0.2%. The recovery results were found 
within acceptance criteria. The developed method 
found to be accurate for determination of assay in 
MEM tablets (Table no. 3).  
 
Linearity 
The linearity of the MEM in dissolution medium was 
performed in the range of 50-150µg/ml and found to 
be linear. The representative regression equation was 
found to be y=1.6072x +1.5924 with lowest 
correlation coefficient (r2) was found to be 0.999. The 
linearity was found with in acceptance criteria.  
 
Robustness 
The robustness parameters for chromatographic 
method are presented in table IV and found within 
acceptance criteria (Table no. 4).  
 
Table 3: Accuracy (Recovery) results 
Concentration level % Recovery Mean % Recovery 
80% 100.2 
99.8±0.5 99.8 
99.3 
100% 99.9 
100.1±0.5 100.6 
99.7 
120% 100.3 
100.1±0.1 99.9 
100.2 
% Mean Recovery 100.0±0.2 
 
Table 4: Robustness results 
Parameter %RSD 
Flow (mL/min) 
0.9  0.45 
1.1 0.35 
pH 
5.8 0.91 
6.2 0.68 
Mobile phase composition (change in organic modifier  
2%) 
53 0.85 
57 0.64 
Column oven and detector temperature (±2°C) 
38 0.43 
42 0.32 
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Fig. 3: Representative chromatogram of Memantine HCl standard 
 
Solution stability of sample and standard 
The MEM found to be stable up to 72h in dissolution 
medium at ambient temperature. The difference 
between the initial results and after 72h was found to 
be 0.5%. 
 
Application of developed method: 
The proposed validated method was used for 
determination of assay in MEM tablets and the 
results were found within the specification (98.5%). 
 
DISCUSSION: 
MEM lacs chromophore, due to this limitation, MEM 
cannot be readily assayed by HPLC-UV techniques 
and hence refractive index detector was selected for 
detection. During development of this method, 
method optimization was carried out by using 
different HPLC columns, by changing concentration 
of organic modifier (methanol) and also different pH 
to achieve the separation between impurity and 
MEM. The main peak of MEM in the proposed 
method was found at 7.0 min. (Fig. 3). The sensitivity 
of standard and sample at concentration 100 µg/mL 
of MEM was found good. 
The method was found economical, simple and 
robust. The system suitability was found to be with 
acceptance criteria. The proposed method is more 
accurate and time saving than the current published 
methods. It can be used by laboratories to determine 
the assay of memantine hydrochloride tablets of 
different strengths. The refractive index detector is a 
universal detector and easily available. Analyst need 
not to do derivatization of drug which is complex and 
time consuming. 
 
CONCLUSION:  
The validation of the method proven that the method 
is linear in the range of 50–150 µg/ml, to be precise 
and accurate over the range.  The validation of the 
method is done accordingly to ICH Q2 (R1) and USP 
38. All the parameters are meeting the acceptance 
criteria. Since method is simple and time saving 
hence it can be used conveniently by laboratories to 
determine the assay of different formulations of 
MEM.  
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